{"pageContent": "Purpose: We assessed the midterm oncologic outcomes of vascular targeted photodynamic therapy with padeliporfin for low risk prostate cancer treatment.", "metaData": {"source": "Radiotherapy: Secondary malignancies after prostate cancer treatment\nhttps://pubmed.ncbi.nlm.nih.gov/20428221/"}}